Healthcare consulting
JLN Health · Healthcare Consulting

Healthcare strategy from market access to execution.

Pharmaceutical, payer, and provider consulting for organizations that intend to act, not just analyze.

Scroll
20+
Years shaping healthcare strategy across pharma, payer, and provider
150+
Engagements from product launch to provider operations
3
Core service groups spanning the full access journey
Introduction

JLN Health

Healthcare Strategy Consulting

JLN Health is an independent healthcare strategy consulting practice. We help pharmaceutical companies, health plans, and care providers turn clinical and market evidence into commercial strategy, market access, and operational performance. This website introduces JLN Health's services, experience, and contact information for prospective clients.

Strategy only matters once it reaches execution. JLN Health stands at the inflection points of commercial strategy, market access, and provider operations, turning evidence into action that holds up before payers, patients, and the P&L.

More about JLN Health
Three service groups

From pharmaceutical strategy to provider operations.

01

Pharmaceutical Consulting

Commercial strategy and execution across the full product lifecycle, grounded in the evidence payers actually weigh.

  • Brand & launch strategy
  • KOL engagement planning
  • Lifecycle management
  • Secondary research insights
02

Market Access & Contracting

Payer strategy and value-based contracting designed for access that survives formulary and negotiation.

  • Payer evidence dossiers
  • Value-based contracting design
  • Formulary positioning
  • Access landscape analysis
03

Provider Performance

Operational improvement for provider organizations and care teams, where strategy meets the daily work of care.

  • Service line optimization
  • Population health strategy
  • Cost-of-care reduction
  • Care model design
Experience

Two decades of engagements across national payers, biopharma launches, and integrated delivery networks, built on the conviction that access decisions should rest on evidence, not optimism.

See representative engagements
National access and network coverage
Where we work
Brand & launch strategy
KOL engagement planning
Lifecycle management
Secondary research insights
Payer evidence dossiers
Value-based contracting design

Strategy deserves to reach execution.

Start a Conversation